AMENDMENT NO. 3 TO THE DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • August 6th, 2020 • Pfenex Inc. • Pharmaceutical preparations
This Amendment No. 3 to the Development and License Agreement (“Amendment No. 3”) is entered into as of May 26, 2020 (“Amendment No. 3 Effective Date”) by and between Pfenex Inc., a Delaware corporation (“Pfenex” or “Party”) and Alvogen Malta (Out-Licensing) Ltd., a Maltese corporation (“Alvogen” or “Party”, and together with Pfenex, the “Parties”).
AMENDMENT NO. 2 TO THE DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • August 6th, 2020 • Pfenex Inc. • Pharmaceutical preparations • New York
This Amendment No. 2 to the Development and License Agreement (this “Amendment #2”) is effective this 24th day of June, 2020 (the “Amendment #2 Effective Date”) by and between Pfenex Inc., a Delaware corporation (“Pfenex”), and Alvogen Malta Operations Ltd., a Maltese corporation (“Alvogen”). Pfenex and Alvogen are sometimes collectively referred to herein as the “Parties” and separately as a “Party.”
